Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Safety Study of Pioglitazone Therapy for Diabetes on Macular Thickness and Vision in Type 2 Diabetes

NCT00548158 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT00548158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Safety Study of Pioglitazone Therapy for Diabetes on Macular Thickness and Vision in Type 2 Diabetes
Lead sponsor
University of California, San Diego
Phase
Observational
Overall status
Completed
Start date
October 31, 2004
Completion date
April 30, 2006
Enrollment
19 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes